In this article, we are going to take a look at where Precigen, Inc. (NASDAQ:PGEN) stands against other hot biotech stocks under $5. The biotechnology sector is gaining new momentum with better ...

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that the Company ...

Precigen (PGEN) reported better-than-expected first-quarter earnings and is making strides toward commercializing its lead asset, PRGN-2012, for recurrent respiratory papillomatosis. The FDA has ...

$PGEN ($PGEN) is expected to release its quarterly earnings data on Wednesday, March 19th after market close, per Finnhub. Analysts are expecting revenue of ...

4 analysts have expressed a variety of opinions on Precigen PGEN over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a concise overview of ...

Knight-Swift Transportation Posts Upbeat Earnings, Joins TAL Education, LSI Industries, GE Aerospace And Other Big Stocks Moving Higher On Thursday ...